Track the Orchard Therapeutics plc stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Orchard Therapeutics plc has recorded 10 reports. Market capitalisation: €11.5m. The latest transaction was reported on 24 January 2024 (Disposition). Among the most active insiders: THOMAS FRANK E. The full history is accessible without an account.
10
Insider Decl.
0
Thresholds
€16,762
2 ops.
Buy Volume
·
6 ops.
Sell Volume
54Σ signal
Buys €16,762· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,548 of 25,973 companies
70.8
score / 100
Value
81
Quality
61
FCF yld12%
Earn yld15%
EV/EBITDA9.2x
ROE15%
Gross mgn45%
Net mgn22%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.